Pfizer Inc.



Sort by : relevance - date - popularity
+Vote!

Health Canada Studying If It Will Follow U.S. FDA In Placing Black Box Warnings On Anti-Smoking Drugs

The results of talks between Health Canada and Pfizer Inc. will determine the course of action Ottawa will make if it will place safety warnings on packaging of anti-smoking drugs known to have psychiatric side effects such as suicidal thoughts. Health Canada spokesperson Philippe Laroche said the agency expects an agreement with Pfizer may be signed by end of summer or fall.

+Vote!

Newsmax.com - Suicide Warning Ordered on Anti-Smoking Drugs

Newsmax.com - Suicide Warning Ordered on Anti-Smoking Drugs By: Susan Heavey U.S. health officials on Wednesday ordered Pfizer Inc and GlaxoSmithKline PLC to add strong "black box" warnings on their anti-smoking drugs to highlight the risk of serious mental health problems, including suicidal thoughts. The warnings, which must be added to Pfizer's Chantix and Glaxo's Zyban, follow more than...

1Vote!

Pfizer Updates CHANTIX(R) (varenicline) Labeling In The United States

Pfizer Inc announced that it has updated the U.S. product labeling for CHANTIX® (varenicline), a prescription aid to smoking cessation treatment, to communicate important safety information in a boxed warning as well as in revised warnings and precautions. These updates are based on post-marketing reports and are being made in agreement with the U.S. Food and Drug Administration (FDA).

+Vote!

U.S. Orders Suicide Warnings On Two Anti-Smoking Drugs

U.S. health officials on Wednesday ordered Pfizer Inc and GlaxoSmithKline PLC to add strong "black box" warnings on their anti-smoking drugs to highlight the risk of serious mental health problems....

1Vote!

Pfizer Discontinues Phase 3 Trial Of Sutent(R) In Metastatic Colorectal Cancer

Pfizer Inc announced the discontinuation of the SUN 1122 Phase 3 trial that evaluated Sutent® (sunitinib malate) plus FOLFIRI (irinotecan plus infusional 5-fluorouracil and leucovorin) versus FOLFIRI alone for the first-line treatment of metastatic colorectal cancer (CRC).

+Vote!

U.S. orders suicide warnings on two anti-smoking drugs

WASHINGTON (Reuters) - U.S. health officials on Wednesday ordered Pfizer Inc and GlaxoSmithKline PLC to add strong "black box" warnings on their anti-smoking drugs to highlight the risk of serious mental health problems, including suicidal thoughts.

1Vote!

U.S. orders suicide warnings on two anti-smoking drugs

U.S. health officials on Wednesday ordered Pfizer Inc and GlaxoSmithKline PLC to add strong "black box" warnings on their anti-smoking drugs to highlight the risk of serious mental health problems, including suicidal thoughts.

+Vote!

Cory Watson Crowder & DeGaris : FDA Black Box Warning for Pfizer Smoking Cessation Drug Chantix(R); Cory Watson Crowder and DeGaris Charges Pfizer Knew of Potential Chantix Dangers

BIRMINGHAM, AL (MARKET WIRE) The FDA has mandated a "Black Box Warning" requiring Pfizer Inc., manufacturer of Chantix(R), to strengthen warnings about the health risks and dangers associated with using the drug. Chantix(R) (varenicline) is advertised as an aid to help people quit smoking. The order for a Boxed Warning comes on the heels of reports linking Chantix(R) to serious injuries and...

+Vote!

Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer

NEW YORK--(BUSINESS WIRE)--Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc. (NYSE: PFE) today announced that they have entered into an Acquisition and License Agreement by

7Vote!

Chantix, Zyban Issued Suicide Warning By FDA

NEW YORK — The Food and Drug Administration will require two smoking-cessation drugs, Chantix and Zyban, to carry the agency's strongest safety warning over side effects including depression and suicidal thoughts. The new requirement, called a "Black Box" warning, is based on reports of people experiencing unusual changes in behavior, becoming depressed, or having suicidal thoughts...

+Vote!

FDA orders harsher warnings on Zyban, Chantix

BOSTON (MarketWatch) -- The Food and Drug Administration said Wednesday that it wants harsher warning labels on the smoking-cessation products Zyban and Chantix, advising that they can trigger serious mood swings, hostile behavior and suicidal thoughts in some users. Zyban is marketed by GlaxoSmithKline PLC while Chantix is sold by Pfizer Inc. The agency is requiring that the products now carry "boxed"...

+Vote!

FDA requires Chantix to have mental health warning

NEW YORK - The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts. The new req ...

+Vote!

FDA to require warnings for Chantix, Zyban

WASHINGTON, July 1 (UPI) -- The U.S. Food and Drug Administration announced Wednesday it will require a boxed warning for the smoking cessation drugs Chantix and Zyban. The FDA said the boxed warning -- the strongest warning the agency can require -- will appear on the package insert. It will highlight the risk of serious mental health events, including changes in behavior, depressed mood, hostility...

+Vote!

FDA requires Chantix to have mental health warning

NEW YORK — The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts.

3Vote!

FDA requires Chantix to have mental health warning

The Food and Drug Administration will require Pfizer Inc.'s smoking cessation drug Chantix to carry the agency's strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts.